Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $2.7 million.

  • Coeptis Therapeutics Holdings' Total Current Liabilities fell 2136.17% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 2136.17%. This contributed to the annual value of $4.5 million for FY2024, which is 5101.26% up from last year.
  • Coeptis Therapeutics Holdings' Total Current Liabilities amounted to $2.7 million in Q3 2025, which was down 2136.17% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Total Current Liabilities ranged from a high of $5.7 million in Q1 2025 and a low of $31816.0 during Q1 2021
  • Its 5-year average for Total Current Liabilities is $2.4 million, with a median of $2.6 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Coeptis Therapeutics Holdings' Total Current Liabilities was 397604.53% (2022), while the steepest drop was 2142.2% (2022).
  • Over the past 5 years, Coeptis Therapeutics Holdings' Total Current Liabilities (Quarter) stood at $2.8 million in 2021, then decreased by 21.42% to $2.2 million in 2022, then surged by 37.56% to $3.0 million in 2023, then soared by 51.01% to $4.5 million in 2024, then crashed by 40.06% to $2.7 million in 2025.
  • Its Total Current Liabilities stands at $2.7 million for Q3 2025, versus $4.5 million for Q2 2025 and $5.7 million for Q1 2025.